ahlam1399
09-04-2015, 03:13 PM
Cosmo gets U.S. approval for agent aimed at easing polyp removal
ZURICH (Reuters) - Cosmo Pharmaceuticals SA said on Friday that the U.S. Food and Drug Administration has given marketing authorization for SIC 8000, a product used in gastrointestinal tract procedures.
http://rc.feedsportal.com/r/238385210686/u/49/f/654207/c/35217/s/499118ec/sc/21/rc/1/rc.img (http://rc.feedsportal.com/r/238385210686/u/49/f/654207/c/35217/s/499118ec/sc/21/rc/1/rc.htm)
http://rc.feedsportal.com/r/238385210686/u/49/f/654207/c/35217/s/499118ec/sc/21/rc/2/rc.img (http://rc.feedsportal.com/r/238385210686/u/49/f/654207/c/35217/s/499118ec/sc/21/rc/2/rc.htm)
http://rc.feedsportal.com/r/238385210686/u/49/f/654207/c/35217/s/499118ec/sc/21/rc/3/rc.img (http://rc.feedsportal.com/r/238385210686/u/49/f/654207/c/35217/s/499118ec/sc/21/rc/3/rc.htm)
http://da.feedsportal.com/r/238385210686/u/49/f/654207/c/35217/s/499118ec/sc/21/a2.img (http://da.feedsportal.com/r/238385210686/u/49/f/654207/c/35217/s/499118ec/sc/21/a2.htm)
http://adchoice.feedsportal.com/r/238385210686/u/49/f/654207/c/35217/s/499118ec/sc/21/ach.img (http://adchoice.feedsportal.com/r/238385210686/u/49/f/654207/c/35217/s/499118ec/sc/21/ach.htm)http://pi.feedsportal.com/r/238385210686/u/49/f/654207/c/35217/s/499118ec/sc/21/a2t.imghttp://pi2.feedsportal.com/r/238385210686/u/49/f/654207/c/35217/s/499118ec/sc/21/a2t2.imghttp://i1.wp.com/reuters.us.feedsportal.com/c/35217/f/654207/s/499118ec/sc/21/mf.gif?resize=1%2C1http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/healthNews?a=lmympcIjvrQ:48Qbgl-qly8:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/healthNews?i=lmympcIjvrQ:48Qbgl-qly8:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/healthNews?a=lmympcIjvrQ:48Qbgl-qly8:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/healthNews?i=lmympcIjvrQ:48Qbgl-qly8:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/healthNews?a=lmympcIjvrQ:48Qbgl-qly8:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/healthNews/~4/lmympcIjvrQ
ZURICH (Reuters) - Cosmo Pharmaceuticals SA said on Friday that the U.S. Food and Drug Administration has given marketing authorization for SIC 8000, a product used in gastrointestinal tract procedures.
http://rc.feedsportal.com/r/238385210686/u/49/f/654207/c/35217/s/499118ec/sc/21/rc/1/rc.img (http://rc.feedsportal.com/r/238385210686/u/49/f/654207/c/35217/s/499118ec/sc/21/rc/1/rc.htm)
http://rc.feedsportal.com/r/238385210686/u/49/f/654207/c/35217/s/499118ec/sc/21/rc/2/rc.img (http://rc.feedsportal.com/r/238385210686/u/49/f/654207/c/35217/s/499118ec/sc/21/rc/2/rc.htm)
http://rc.feedsportal.com/r/238385210686/u/49/f/654207/c/35217/s/499118ec/sc/21/rc/3/rc.img (http://rc.feedsportal.com/r/238385210686/u/49/f/654207/c/35217/s/499118ec/sc/21/rc/3/rc.htm)
http://da.feedsportal.com/r/238385210686/u/49/f/654207/c/35217/s/499118ec/sc/21/a2.img (http://da.feedsportal.com/r/238385210686/u/49/f/654207/c/35217/s/499118ec/sc/21/a2.htm)
http://adchoice.feedsportal.com/r/238385210686/u/49/f/654207/c/35217/s/499118ec/sc/21/ach.img (http://adchoice.feedsportal.com/r/238385210686/u/49/f/654207/c/35217/s/499118ec/sc/21/ach.htm)http://pi.feedsportal.com/r/238385210686/u/49/f/654207/c/35217/s/499118ec/sc/21/a2t.imghttp://pi2.feedsportal.com/r/238385210686/u/49/f/654207/c/35217/s/499118ec/sc/21/a2t2.imghttp://i1.wp.com/reuters.us.feedsportal.com/c/35217/f/654207/s/499118ec/sc/21/mf.gif?resize=1%2C1http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/healthNews?a=lmympcIjvrQ:48Qbgl-qly8:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/healthNews?i=lmympcIjvrQ:48Qbgl-qly8:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/healthNews?a=lmympcIjvrQ:48Qbgl-qly8:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/healthNews?i=lmympcIjvrQ:48Qbgl-qly8:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/healthNews?a=lmympcIjvrQ:48Qbgl-qly8:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/healthNews/~4/lmympcIjvrQ